Aspartate-β-hydroxylase (ASPH): A potential therapeutic target in human malignant gliomas

BACKGROUND: Despite therapeutic advances, survival with glioblastoma multiforme (GBM) remains below 15 months from diagnosis due to GBM’s highly infiltrative nature which precludes complete surgical resection. Patient outcomes could potentially be improved by targeting genes and pathways that drive...

Descripción completa

Detalles Bibliográficos
Autores principales: Sturla, Lisa-Marie, Tong, Ming, Hebda, Nick, Gao, Jinsong, Thomas, John-Michael, Olsen, Mark, de la Monte, Suzanne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144823/
https://www.ncbi.nlm.nih.gov/pubmed/27981247
http://dx.doi.org/10.1016/j.heliyon.2016.e00203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144823/
https://www.ncbi.nlm.nih.gov/pubmed/27981247
http://dx.doi.org/10.1016/j.heliyon.2016.e00203

Ejemplares similares